We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

84 hedge funds and large institutions have $31.7M invested in Tempest Therapeutics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

5% more funds holding

Funds holding: 80 → 84 (+4)

85% less capital invested

Capital invested by funds: $206M → $31.7M (-$175M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $38K

Holders
84
Holders Change
+4
Holders Change %
+5%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
21
Reduced
13
Closed
16
Calls
–
Puts
$38K
Net Calls
-$38K
Net Calls Change
+$49K

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$1.77M
2
Millennium Management
Millennium Management
New York
+$1.57M
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$1.32M
4
Morgan Stanley
Morgan Stanley
New York
+$473K
5
AIC
AWM Investment Company
New York
+$424K

Top Sellers

Rank Fund Capital Flow
1
OAG
Orbis Allan Gray
Bermuda
-$18.9M
2
JHIU
Janus Henderson Investors US
Colorado
-$16.4M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$12.1M
4
Jennison Associates
Jennison Associates
New York
-$3.31M
5
Asset Management One
Asset Management One
Japan
-$2.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
76
Russell Investments Group
United Kingdom
$10K +$24.9K +2 New
MAM
77
Meeder Asset Management
Ohio
$6K +$12.5K +1 New
Simplex Trading
78
Simplex Trading
Illinois
$6K +$12.5K +1 New
Canada Life
79
Canada Life
Manitoba, Canada
$5K – – –
CLOS
80
Compagnie Lombard Odier SCmA
Switzerland
$5K – – –
BNP Paribas Financial Markets
81
BNP Paribas Financial Markets
France
$3.06K – – –
Bank of Montreal
82
Bank of Montreal
Ontario, Canada
$3K – – –
MFS
83
MSI Financial Services
Massachusetts
$3K – – –
Royal Bank of Canada
84
Royal Bank of Canada
Ontario, Canada
$3K +$12.5K +1 New
BWM
85
Baystate Wealth Management
Massachusetts
$2K – – –
TDC
86
Thompson Davis & Co
Virginia
$2K – – –
TCOV
87
Trust Company of Vermont
Vermont
$2K – – –
AG
88
Advisor Group
Arizona
$1K – – –
PAM
89
Panagora Asset Management
Massachusetts
$1K – – –
Zurich Cantonal Bank
90
Zurich Cantonal Bank
Switzerland
$1K – – –
OAG
91
Orbis Allan Gray
Bermuda
– -$18.9M -902 Closed
ACH
92
ArrowMark Colorado Holdings
Colorado
– -$12.1M -578 Closed
Asset Management One
93
Asset Management One
Japan
– -$2.22M -105 Closed
Fuller & Thaler Asset Management
94
Fuller & Thaler Asset Management
California
– -$1.5M -72 Closed
HCM
95
Highbridge Capital Management
New York
– -$350K -17 Closed
GS
96
Gagnon Securities
New York
– -$307K -15 Closed
PPA
97
Parametric Portfolio Associates
Washington
– -$286K -14 Closed
NI
98
Numeric Investors
Massachusetts
– -$255K -12 Closed
MLICM
99
Metropolitan Life Insurance Company (MetLife)
New York
– -$190K -9 Closed
ProShare Advisors
100
ProShare Advisors
Maryland
– -$182K -9 Closed
1 2 3
4
5

TPST Hedge Fund Activity: Q4 2016 in Review

84 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2016, worth a combined $31.7M — down 85% from $206M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TPST positions and 16 closed out — a net gain of 4 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $1.77M. The largest seller was Orbis Allan Gray, exiting entirely with an estimated $18.9M sold.

  • 84 institutional investors held Tempest Therapeutics (TPST) as of Q4 2016, up from 80 in Q3 2016.
  • Funds reported $31.7M of Tempest Therapeutics stock for Q4 2016, down 85% quarter-over-quarter.
  • 20 funds opened new Tempest Therapeutics positions in Q4 2016 and 16 closed out, a net change of +4 holders.
  • The largest Tempest Therapeutics buyer in Q4 2016 was Anson Funds Management, an estimated $1.77M added.
  • The largest Tempest Therapeutics seller in Q4 2016 was Orbis Allan Gray, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2016.